PMC:7600245 / 96917-97676
Annnotations
LitCovid_Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 167-174 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T2 | 167-174 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T3 | 199-207 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparins |
| T4 | 199-207 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparins |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T449 | 167-174 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
| T450 | 199-207 | Body_part | denotes | heparins | http://purl.org/sig/ont/fma/fma82839 |
| T451 | 267-285 | Body_part | denotes | glycosaminoglycans | http://purl.org/sig/ont/fma/fma63011 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T437 | 74-82 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T964 | 83-84 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T965 | 150-151 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | b |
| T966 | 287-297 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | Activation |
| T967 | 575-576 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T968 | 704-705 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T969 | 731-732 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | b |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T734 | 167-174 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
| T735 | 199-207 | Chemical | denotes | heparins | http://purl.obolibrary.org/obo/CHEBI_24505 |
| T736 | 209-219 | Chemical | denotes | Enoxaparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
| T737 | 258-285 | Chemical | denotes | Sulfated glycosaminoglycans | http://purl.obolibrary.org/obo/CHEBI_35722 |
| T738 | 267-285 | Chemical | denotes | glycosaminoglycans | http://purl.obolibrary.org/obo/CHEBI_18085 |
| T739 | 353-360 | Chemical | denotes | Aspirin | http://purl.obolibrary.org/obo/CHEBI_15365 |
| T740 | 362-382 | Chemical | denotes | Acetylsalicylic acid | http://purl.obolibrary.org/obo/CHEBI_15365 |
| T741 | 378-382 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
| T742 | 391-399 | Chemical | denotes | molecule | http://purl.obolibrary.org/obo/CHEBI_25367 |
| T743 | 417-426 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T744 | 443-450 | Chemical | denotes | Xarelto | http://purl.obolibrary.org/obo/CHEBI_68579 |
| T745 | 459-467 | Chemical | denotes | molecule | http://purl.obolibrary.org/obo/CHEBI_25367 |
| T746 | 476-495 | Chemical | denotes | factor Xa inhibitor | http://purl.obolibrary.org/obo/CHEBI_68581 |
| T747 | 486-495 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T748 | 530-538 | Chemical | denotes | molecule | http://purl.obolibrary.org/obo/CHEBI_25367 |
| T749 | 540-550 | Chemical | denotes | Nucleoside | http://purl.obolibrary.org/obo/CHEBI_33838 |
| T750 | 561-570 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T751 | 597-606 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T90414 | 623-629 | Chemical | denotes | Plavix | http://purl.obolibrary.org/obo/CHEBI_3759 |
| T753 | 638-646 | Chemical | denotes | molecule | http://purl.obolibrary.org/obo/CHEBI_25367 |
| T754 | 661-670 | Chemical | denotes | adenosine | http://purl.obolibrary.org/obo/CHEBI_16335 |
| T755 | 671-682 | Chemical | denotes | diphosphate | http://purl.obolibrary.org/obo/CHEBI_18361|http://purl.obolibrary.org/obo/CHEBI_33019 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T194 | 540-560 | http://purl.obolibrary.org/obo/GO_0015858 | denotes | Nucleoside transport |
| T195 | 551-560 | http://purl.obolibrary.org/obo/GO_0006810 | denotes | transport |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T804 | 0-85 | Sentence | denotes | Table 3 Most frequently evaluated antithrombotics in clinical trials for COVID-19 a. |
| T805 | 86-151 | Sentence | denotes | Therapy Type Mechanism No. of Interventional Clinical Trials b |
| T806 | 152-352 | Sentence | denotes | Unfractionated heparin or Low molecular weight heparins (Enoxaparin, Dalteparin, Tinzaparin, and others) Sulfated glycosaminoglycans Activation of antithrombin to inhibit thrombin and factor Xa ~23 |
| T807 | 353-430 | Sentence | denotes | Aspirin (Acetylsalicylic acid) Small molecule Cyclo-oxygenase inhibitor ~8 |
| T808 | 431-499 | Sentence | denotes | Rivaroxaban(Xarelto) Small molecule Direct factor Xa inhibitor ~5 |
| T809 | 500-610 | Sentence | denotes | Dipyridamole(Aggrenox) Small molecule Nucleoside transport inhibitor and a phosphodiesterase 3 inhibitor ~3 |
| T810 | 611-703 | Sentence | denotes | Clopidogrel(Plavix) Small molecule Irreversible adenosine diphosphate receptor blocker ~3 |
| T811 | 704-759 | Sentence | denotes | a From clinicaltrials.gov, b No. is as of 25 July 2020. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 4100 | 301-313 | Gene | denotes | antithrombin | Gene:462 |
| 4101 | 325-333 | Gene | denotes | thrombin | Gene:2147 |
| 4102 | 167-174 | Chemical | denotes | heparin | MESH:D006493 |
| 4103 | 661-670 | Chemical | denotes | adenosine | MESH:D000241 |
| 4105 | 74-82 | Disease | denotes | COVID-19 | MESH:C000657245 |